301 related articles for article (PubMed ID: 8016110)
21. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades.
Gum R; Wang H; Lengyel E; Juarez J; Boyd D
Oncogene; 1997 Mar; 14(12):1481-93. PubMed ID: 9136992
[TBL] [Abstract][Full Text] [Related]
22. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
Okumura K; Shirasawa S; Nishioka M; Sasazuki T
Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
[TBL] [Abstract][Full Text] [Related]
23. Cross-cascade activation of ERKs and ternary complex factors by Rho family proteins.
Frost JA; Steen H; Shapiro P; Lewis T; Ahn N; Shaw PE; Cobb MH
EMBO J; 1997 Nov; 16(21):6426-38. PubMed ID: 9351825
[TBL] [Abstract][Full Text] [Related]
24. Stimulation of the P-450 side chain cleavage enzyme (CYP11A1) promoter through ras- and Ets-2-signaling pathways.
Pestell RG; Albanese C; Watanabe G; Lee RJ; Lastowiecki P; Zon L; Ostrowski M; Jameson JL
Mol Endocrinol; 1996 Sep; 10(9):1084-94. PubMed ID: 8885243
[TBL] [Abstract][Full Text] [Related]
25. A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum.
Frost JA; Geppert TD; Cobb MH; Feramisco JR
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3844-8. PubMed ID: 8170999
[TBL] [Abstract][Full Text] [Related]
26. Platelet-derived growth factor stimulation of mitogen-activated protein kinases and cyclin D1 promoter activity in cultured airway smooth-muscle cells. Role of Ras.
Page K; Li J; Hershenson MB
Am J Respir Cell Mol Biol; 1999 Jun; 20(6):1294-302. PubMed ID: 10340949
[TBL] [Abstract][Full Text] [Related]
27. The extracellular-signal-regulated protein kinases (Erks) are required for UV-induced AP-1 activation in JB6 cells.
Huang C; Ma WY; Dong Z
Oncogene; 1999 May; 18(18):2828-35. PubMed ID: 10362253
[TBL] [Abstract][Full Text] [Related]
28. junB promoter regulation: Ras mediated transactivation by c-Ets-1 and c-Ets-2.
Coffer P; de Jonge M; Mettouchi A; Binetruy B; Ghysdael J; Kruijer W
Oncogene; 1994 Mar; 9(3):911-21. PubMed ID: 8108135
[TBL] [Abstract][Full Text] [Related]
29. c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases.
Minden A; Lin A; Smeal T; Dérijard B; Cobb M; Davis R; Karin M
Mol Cell Biol; 1994 Oct; 14(10):6683-8. PubMed ID: 7935387
[TBL] [Abstract][Full Text] [Related]
30. Protein kinase C isoforms involved in the transcriptional activation of cyclin D1 by transforming Ha-Ras.
Kampfer S; Windegger M; Hochholdinger F; Schwaiger W; Pestell RG; Baier G; Grunicke HH; Uberall F
J Biol Chem; 2001 Nov; 276(46):42834-42. PubMed ID: 11551901
[TBL] [Abstract][Full Text] [Related]
31. Cells transformed by ODC, c-Ha-ras and v-src exhibit MAP kinase/Erk-independent constitutive phosphorylation of Sos, Raf and c-Jun activation domain, and reduced PDGF receptor expression.
Paasinen-Sohns A; Hölttä E
Oncogene; 1997 Oct; 15(16):1953-66. PubMed ID: 9365242
[TBL] [Abstract][Full Text] [Related]
32. The stress-activated protein kinase subfamily of c-Jun kinases.
Kyriakis JM; Banerjee P; Nikolakaki E; Dai T; Rubie EA; Ahmad MF; Avruch J; Woodgett JR
Nature; 1994 May; 369(6476):156-60. PubMed ID: 8177321
[TBL] [Abstract][Full Text] [Related]
33. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation.
Khosravi-Far R; White MA; Westwick JK; Solski PA; Chrzanowska-Wodnicka M; Van Aelst L; Wigler MH; Der CJ
Mol Cell Biol; 1996 Jul; 16(7):3923-33. PubMed ID: 8668210
[TBL] [Abstract][Full Text] [Related]
34. Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2).
Koong AC; Chen EY; Mivechi NF; Denko NC; Stambrook P; Giaccia AJ
Cancer Res; 1994 Oct; 54(20):5273-9. PubMed ID: 7923153
[TBL] [Abstract][Full Text] [Related]
35. Role of mitogen-activated protein kinases and c-Jun/AP-1 trans-activating activity in the regulation of protease mRNAs and the malignant phenotype in NIH 3T3 fibroblasts.
Janulis M; Silberman S; Ambegaokar A; Gutkind JS; Schultz RM
J Biol Chem; 1999 Jan; 274(2):801-13. PubMed ID: 9873019
[TBL] [Abstract][Full Text] [Related]
36. 1alpha,25-dihydroxyvitamin D3 stimulates activator protein 1 DNA-binding activity by a phosphatidylinositol 3-kinase/Ras/MEK/extracellular signal regulated kinase 1/2 and c-Jun N-terminal kinase 1-dependent increase in c-Fos, Fra1, and c-Jun expression in human keratinocytes.
Johansen C; Kragballe K; Henningsen J; Westergaard M; Kristiansen K; Iversen L
J Invest Dermatol; 2003 Apr; 120(4):561-70. PubMed ID: 12648218
[TBL] [Abstract][Full Text] [Related]
37. Novel membrane-targeted ERK1 and ERK2 chimeras which act as dominant negative, isotype-specific mitogen-activated protein kinase inhibitors of Ras-Raf-mediated transcriptional activation of c-fos in NIH 3T3 cells.
Hochholdinger F; Baier G; Nogalo A; Bauer B; Grunicke HH; Uberall F
Mol Cell Biol; 1999 Dec; 19(12):8052-65. PubMed ID: 10567531
[TBL] [Abstract][Full Text] [Related]
38. Regulation of mitogen-activated protein kinases by a calcium/calmodulin-dependent protein kinase cascade.
Enslen H; Tokumitsu H; Stork PJ; Davis RJ; Soderling TR
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10803-8. PubMed ID: 8855261
[TBL] [Abstract][Full Text] [Related]
39. C3 toxin activates the stress signaling pathways, JNK and p38, but antagonizes the activation of AP-1 in rat-1 cells.
Beltman J; Erickson JR; Martin GA; Lyons JF; Cook SJ
J Biol Chem; 1999 Feb; 274(6):3772-80. PubMed ID: 9920930
[TBL] [Abstract][Full Text] [Related]
40. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation.
Watts RG; Huang C; Young MR; Li JJ; Dong Z; Pennie WD; Colburn NH
Oncogene; 1998 Dec; 17(26):3493-8. PubMed ID: 10030673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
